Xing PY - Search Results

1

Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer.

Xing PY, Li JL, Wang Y, Hao XZ, Wang B, Yang L, Shi YK, Zhang XR. Xing PY, et al. Chin J Cancer Res. 2013 Apr;25(2):200-5. doi: 10.3978/j.issn.1000-9604.2013.03.04. Chin J Cancer Res. 2013. PMID: 23592901 Free PMC article.

2

[Clinical characteristics and treatment of desmoplastic small round cell tumor].

Xing PY, Shi YK, Feng FY, Qin Y, Liu P. Xing PY, et al. Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):139-42. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20403246 Review. Chinese.

3

[Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity].

Dong M, Xing PY, Liu P, Feng FY, Shi YK. Dong M, et al. Among authors: xing py. Zhonghua Zhong Liu Za Zhi. 2010 Mar;32(3):208-11. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20450590 Clinical Trial. Chinese.

4

Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas.

Dong M, Ning ZQ, Xing PY, Xu JL, Cao HX, Dou GF, Meng ZY, Shi YK, Lu XP, Feng FY. Dong M, et al. Among authors: xing py. Cancer Chemother Pharmacol. 2012 Jun;69(6):1413-22. doi: 10.1007/s00280-012-1847-5. Epub 2012 Feb 24. Cancer Chemother Pharmacol. 2012. PMID: 22362161 Clinical Trial.

5

[Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].

Xing PY, Shi YK, He XH, Zhou LQ, Dong M, Yang JL, Liu P. Xing PY, et al. Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):692-7. doi: 10.3760/cma.j.issn.0253-3766.2012.09.011. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23159084 Chinese.

6

[Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small cell lung cancer].

Xing P, Li J, Shi Y. Xing P, et al. Zhongguo Fei Ai Za Zhi. 2013 Oct 20;16(10):519-23. doi: 10.3779/j.issn.1009-3419.2013.10.04. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24113004 Free PMC article. Chinese.

7

[Treatment choice for advanced non-small cell lung cancer patients who had gradual progression after EGFR-TKIs: 32 cases report].

Lin L, Wang B, Hao X, Xing P, Li J, Zhang X, Shi Y. Lin L, et al. Zhongguo Fei Ai Za Zhi. 2013 Oct 20;16(10):524-8. doi: 10.3779/j.issn.1009-3419.2013.10.05. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24113005 Free PMC article. Chinese.

8

[Progress in cancer treatment with histone deacetylase inhibitor].

Dong M, Hu XS, Chen SS, Xing PY, Feng FY, Shi YK. Dong M, et al. Among authors: xing py. Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):481-5. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24257296 Review. Chinese. No abstract available.

9

[Association between different EGFR mutation status and survival in pemetrexed-based chemotherapy for advanced non-small cell lung cancer].

Jia B, He XH, Yang S, Wang ZP, Li JL, Wang Y, Wang HY, Xing PY, Liu YT, Shi YK. Jia B, et al. Among authors: xing py. Zhonghua Yi Xue Za Zhi. 2013 Dec;93(46):3659-62. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24534344 Chinese.

10

Sorafenib in metastatic radioactive iodine-refractory differentiated thyroid cancer: A pilot study.

Luo Y, Shi Y, Xing P, Wang L, Feng Y, Han X, He X. Luo Y, et al. Mol Clin Oncol. 2014 Jan;2(1):87-92. doi: 10.3892/mco.2013.199. Epub 2013 Oct 9. Mol Clin Oncol. 2014. PMID: 24649313 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters